About us

Clinical Genomics Uppsala offers services with a range of molecular methods to researchers with translational or clinical projects. We also develop and implement new diagnostic tests in clinical routine. 

Clinical Genomics Uppsala was jointly set up at Uppsala University and Uppsala University Hospital in 2013, to catalyze the transition of novel research findings into molecular diagnostics for clinical use. Our laboratories are integrated within the sections for Clinical GeneticsClinical Pathology and Clinical Microbiology at the Academic Laboratory at Uppsala University Hospital. We have introduced a range of genetic tests for cancer and inherited diseases that are used on a daily basis to guide treatment decisions.

The facility is part of the Clinical Genomics platform within the infrastructure Science for Life Laboratory (SciLifeLab). We take on research and development projects with a clear translational profile. We offer users services with a range of molecular methods, such as next generation sequencing (NGS), NanoString and digital PCR technologies. With our team of bioinformaticians, geneticists and medical doctors associated to the facility, we can deliver clinical assessments of the detected variants with the aim to truly provide bench-to-bedside service.

Clinical Genomics Uppsala is one of the key players in the Genomic Medicine Sweden initiative, which aims to strengthen precision medicine throughout Sweden. GMS is a collaboration between Sweden’s seven universities with a medical faculty and regions with university hospitals.

Group photo of CGU personnel.
Clinical Genomics Uppsala's team includes biomedical analysts, molecular biologists, bioinformaticians, molecular biologists, clinical molecular geneticists and physicians.

Last modified: 2022-05-13